Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Clinical Research Center for Anesthesiology and Perioperative Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China.
Chin J Integr Med. 2024 Nov;30(11):1035-1044. doi: 10.1007/s11655-024-4106-9. Epub 2024 Jul 29.
To investigate changes of myeloid differentiation factor 2 (MD2) in inflammation-induced pain and acupuncture-mediated analgesia.
Mice were randomly divided into three groups by a random number table method: saline group (n=16), complete Freund's adjuvant (CFA) group (n=24) and CFA+electroacupuncture (EA) group (n=26). Inflammation-induced pain was modelled by injecting CFA to the plantar surface of the hind paw of mice and EA was applied to bilateral Zusanli (ST 36) to alleviate pain. Only mice in the CFA+EA group received EA treatment (30 min/d for 2 weeks) 24 h after modelling. Mice in the saline and CFA groups received sham EA. von-Frey test and Hargreaves test were used to assess the pain threshold. Brain and spinal tissues were collected for immunofluorescence staining or Western blotting to quantify changes of MD2 expression.
CFA successfully induced plantar pain and EA significantly alleviated pain 3 days after modelling (P<0.01). Compared with the CFA group, the number of MD2/c-fos neurons was significantly increased in the dorsal horn of the spinal cord 7 and 14 days after EA, especially in laminae I - II (P<0.01). The proportion of double positive cells to the number of c-fos positive cells and the mean fluorescence intensity of MD2 neurons were also significantly increased in laminae I - II (P<0.01). Western blotting showed that the level of MD2 was significantly decreased by EA only in the hippocampus on day 7 and 14 (both P<0.01) and no significant changes were observed in the cortex, thalamus, cerebellum, or the brainstem (P<0.05). Fluorescence staining showed significant decrease in the level of MD2 in periagueductal gray (PAG) and locus coeruleus (LC) after CFA injection on day 7 (P<0.01 for PAG, P<0.05 for LC) and EA significantly reversed this decrease (P<0.01 for PAG, P<0.05 for LC).
The unique changes of MD2 suggest that EA may exert the analgesic effect through modulating neuronal activities of the superficial laminae of the spinal cord and certain regions of the brain.
探讨髓样分化因子 2(MD2)在炎症诱导痛觉和针刺镇痛中的变化。
采用随机数字表法将小鼠随机分为三组:生理盐水组(n=16)、完全弗氏佐剂(CFA)组(n=24)和 CFA+电针(EA)组(n=26)。通过向小鼠足底皮下注射 CFA 建立炎症诱导痛觉模型,EA 用于缓解疼痛,仅 CFA+EA 组在造模后 24 h 时接受 EA 治疗(30 min/d,持续 2 周)。生理盐水组和 CFA 组接受假 EA。采用 von-Frey 测试和 Hargreaves 测试评估疼痛阈值。采集脑组织和脊髓组织进行免疫荧光染色或 Western blot 分析,以定量检测 MD2 表达变化。
CFA 成功诱导了足底疼痛,EA 显著缓解了造模后 3 天的疼痛(P<0.01)。与 CFA 组相比,EA 后第 7 和 14 天,脊髓背角的 MD2/c-fos 神经元数量明显增加,尤其是在 I - II 层(P<0.01)。I - II 层的双阳性细胞数与 c-fos 阳性细胞数的比例以及 MD2 神经元的平均荧光强度也明显增加(P<0.01)。Western blot 显示,仅在海马组织中,EA 可显著降低 MD2 水平,在第 7 天和第 14 天均有统计学意义(均 P<0.01),而在皮质、丘脑、小脑或脑干中无明显变化(P<0.05)。荧光染色显示,在第 7 天 CFA 注射后,中脑导水管周围灰质(PAG)和蓝斑(LC)的 MD2 水平明显降低(PAG:P<0.01,LC:P<0.05),而 EA 则显著逆转了这种降低(PAG:P<0.01,LC:P<0.05)。
MD2 的独特变化表明,EA 可能通过调节脊髓浅层和某些脑区神经元的活动发挥镇痛作用。